Cipla inks licensing deal with Belgium's MultiG for distribution of COVID-19 antibody test kit

"As part of this agreement, Cipla will be responsible for distribution of the COVID-19 rapid antibody kit that will be manufactured by MultiG" the company added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news